Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $91.35 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GE Healthcare | $16.82 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.07 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $13.86 | 1 | $0 (2019) |
| ABBVIE INC. | $12.24 | 1 | $0 (2022) |
| Mylan Specialty L.P. | $11.43 | 1 | $0 (2018) |
| TETRAPHASE PHARMACEUTICALS, INC. | $11.04 | 1 | $0 (2019) |
| Shire North American Group Inc | $10.89 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $12.24 | 1 | ABBVIE INC. ($12.24) |
| 2019 | $39.97 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($15.07) |
| 2018 | $39.14 | 3 | GE Healthcare ($16.82) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.86 | General |
| Category: Cardiovascular | ||||||
| 03/22/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 01/22/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/20/2018 | GE Healthcare | — | Food and Beverage | Cash or cash equivalent | $16.82 | General |
| 12/19/2018 | Mylan Specialty L.P. | Dymista (Drug), Perforomist | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Respiratory and Allergy | ||||||
| 10/31/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Kevin Hughes, DO
Dr. Kevin Hughes, DO is a Diagnostic Radiology healthcare provider based in Burlington, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124023841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Hughes, DO has received a total of $91.35 in payments from pharmaceutical and medical device companies, with $12.24 received in 2022. These payments were reported across 7 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($91.35).
Practice Information
- Specialty Diagnostic Radiology
- Location Burlington, KS
- Active Since 06/17/2005
- Last Updated 01/17/2020
- Taxonomy Code 2085R0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124023841
Products in Payments
- XIFAXAN (Drug) $15.07
- ELIQUIS (Drug) $13.86
- VRAYLAR (Drug) $12.24
- Dymista (Drug) $11.43
- Xerava (Drug) $11.04
- VYVANSE (Drug) $10.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Burlington
Miklos Marosfoi, Md, MD
Diagnostic Radiology — Payments: $296,146
Juan Small, Md, MD
Diagnostic Radiology — Payments: $269,149
David Rosman, M.d, M.D
Diagnostic Radiology — Payments: $117,880
Neil Patel, M.d, M.D
Diagnostic Radiology — Payments: $24,691
Dr. Jeanette Chun, M.d, M.D
Diagnostic Radiology — Payments: $19,050
Bill Majdalany, M.d, M.D
Diagnostic Radiology — Payments: $18,165